Enter your email address below and subscribe to our newsletter

Research & Studies

Share your love

Editorial: Artificial intelligence and telemedicine: applications to vascular neurology, neuro-ophthalmology, neuro-otology, and epilepsy: advancing teleneurology with artificial intelligence and digital biomarkers – Frontiers

Editorial: Artificial intelligence and telemedicine: applications to vascular neurology, neuro-ophthalmology, neuro-otology, and epilepsy: advancing teleneurology with artificial intelligence and digital biomarkers  Frontiers Source: Author: | Date: 2025-03-24 07:00:00 Source: Author: | Date: 2025-03-24 07:00:00

Glaukos Submits FDA Application for Epioxa Therapy

Glaukos Corporation has officially submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its innovative corneal cross-linking therapy, Epioxa (Epi-on). This next-generation treatment is designed for patients with keratoconus and represents a significant advancement…

NEI Study Reveals Annexin-V’s Role in Retinal Diseases

A recent study led by the National Eye Institute (NEI) has revealed new insights into annexin-V, a key biomarker traditionally used to track apoptosis (programmed cell death) and retinal cell degeneration in eye diseases. Published in the International Journal of…

Stay informed and not overwhelmed, subscribe now!